Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heribert Jürgens

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Future Oncology (London, England)|July 14, 2010
Approaching Ewing sarcomaUta Dirksen, Heribert Jürgens
Advances in Nutrition (Bethesda, Md.)|February 15, 2012
Important aspects of nutrition in children with cancerJacqueline Bauer, Heribert Jürgens, Michael C Frühwald
Pediatric Hematology and Oncology|February 3, 2012
Ewing sarcoma: clinical state-of-the-artJenny Potratz, Uta Dirksen, Heribert Jürgens, et al.
Pediatric Hematology and Oncology|February 7, 2012
Ewing sarcoma: biology-based therapeutic perspectivesJenny Potratz, Heribert Jürgens, Alan Craft, et al.
Klinische Padiatrie|September 5, 2018
[DKG Certification of Paediatric Cancer Centres]Jumana Mensah, Heribert Jürgens, Angelika Eggert, et al.
Cancer Chemotherapy and Pharmacology|August 13, 2002
c-KIT-expressing Ewing tumour cells are insensitive to imatinib mesylate (STI571)Marc Hotfilder, Claudia Lanvers, Heribert Jürgens, et al.
Expert Opinion on Pharmacotherapy|May 28, 2004
Delaying surgery with chemotherapy for osteosarcoma of the extremitiesStefan S Bielack, Jan-Nicolas Machatschek, Silke Flege, et al.
Pediatric Blood & Cancer|July 20, 2007
Ewing tumors in infantsHenk van den Berg, Uta Dirksen, Andreas Ranft, et al.
Anti-Cancer Drugs|August 19, 2006
Cytotoxicity of treosulfan and busulfan on pediatric tumor cell linesClaudia Lanvers-Kaminsky, Alexis Bremer, Uta Dirksen, et al.
Pediatric Blood & Cancer|April 15, 2014
The value of high-dose chemotherapy in patients with first relapsed Ewing sarcomaMeybrit Rasper, Susanne Jabar, Andreas Ranft, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Future Oncology (London, England)|July 14, 2010
Approaching Ewing sarcomaUta Dirksen, Heribert Jürgens
Advances in Nutrition (Bethesda, Md.)|February 15, 2012
Important aspects of nutrition in children with cancerJacqueline Bauer, Heribert Jürgens, Michael C Frühwald
Pediatric Hematology and Oncology|February 3, 2012
Ewing sarcoma: clinical state-of-the-artJenny Potratz, Uta Dirksen, Heribert Jürgens, et al.
Pediatric Hematology and Oncology|February 7, 2012
Ewing sarcoma: biology-based therapeutic perspectivesJenny Potratz, Heribert Jürgens, Alan Craft, et al.
Klinische Padiatrie|September 5, 2018
[DKG Certification of Paediatric Cancer Centres]Jumana Mensah, Heribert Jürgens, Angelika Eggert, et al.
Cancer Chemotherapy and Pharmacology|August 13, 2002
c-KIT-expressing Ewing tumour cells are insensitive to imatinib mesylate (STI571)Marc Hotfilder, Claudia Lanvers, Heribert Jürgens, et al.
Expert Opinion on Pharmacotherapy|May 28, 2004
Delaying surgery with chemotherapy for osteosarcoma of the extremitiesStefan S Bielack, Jan-Nicolas Machatschek, Silke Flege, et al.
Pediatric Blood & Cancer|July 20, 2007
Ewing tumors in infantsHenk van den Berg, Uta Dirksen, Andreas Ranft, et al.
Anti-Cancer Drugs|August 19, 2006
Cytotoxicity of treosulfan and busulfan on pediatric tumor cell linesClaudia Lanvers-Kaminsky, Alexis Bremer, Uta Dirksen, et al.
Pediatric Blood & Cancer|April 15, 2014
The value of high-dose chemotherapy in patients with first relapsed Ewing sarcomaMeybrit Rasper, Susanne Jabar, Andreas Ranft, et al.
Pageof 9